314 related articles for article (PubMed ID: 11090361)
1. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.
Orth K; Xu Z; Mudgett MB; Bao ZQ; Palmer LE; Bliska JB; Mangel WF; Staskawicz B; Dixon JE
Science; 2000 Nov; 290(5496):1594-7. PubMed ID: 11090361
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Xanthomonas AvrXv4 effector, a SUMO protease translocated into plant cells.
Roden J; Eardley L; Hotson A; Cao Y; Mudgett MB
Mol Plant Microbe Interact; 2004 Jun; 17(6):633-43. PubMed ID: 15195946
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia.
Zhang Y; Ting AT; Marcu KB; Bliska JB
J Immunol; 2005 Jun; 174(12):7939-49. PubMed ID: 15944300
[TBL] [Abstract][Full Text] [Related]
4. Function of the Yersinia effector YopJ.
Orth K
Curr Opin Microbiol; 2002 Feb; 5(1):38-43. PubMed ID: 11834367
[TBL] [Abstract][Full Text] [Related]
5. YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction.
Sweet CR; Conlon J; Golenbock DT; Goguen J; Silverman N
Cell Microbiol; 2007 Nov; 9(11):2700-15. PubMed ID: 17608743
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.
Orth K; Palmer LE; Bao ZQ; Stewart S; Rudolph AE; Bliska JB; Dixon JE
Science; 1999 Sep; 285(5435):1920-3. PubMed ID: 10489373
[TBL] [Abstract][Full Text] [Related]
7. Microbiology. Unlocking the secrets of the grim reaper.
Brown K
Science; 2000 Nov; 290(5496):1475. PubMed ID: 11185496
[TBL] [Abstract][Full Text] [Related]
8. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells.
Palmer LE; Pancetti AR; Greenberg S; Bliska JB
Infect Immun; 1999 Feb; 67(2):708-16. PubMed ID: 9916081
[TBL] [Abstract][Full Text] [Related]
9. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation.
Zhou H; Monack DM; Kayagaki N; Wertz I; Yin J; Wolf B; Dixit VM
J Exp Med; 2005 Nov; 202(10):1327-32. PubMed ID: 16301742
[TBL] [Abstract][Full Text] [Related]
10. Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling.
Philip NH; Dillon CP; Snyder AG; Fitzgerald P; Wynosky-Dolfi MA; Zwack EE; Hu B; Fitzgerald L; Mauldin EA; Copenhaver AM; Shin S; Wei L; Parker M; Zhang J; Oberst A; Green DR; Brodsky IE
Proc Natl Acad Sci U S A; 2014 May; 111(20):7385-90. PubMed ID: 24799700
[TBL] [Abstract][Full Text] [Related]
11. The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity.
Schesser K; Spiik AK; Dukuzumuremyi JM; Neurath MF; Pettersson S; Wolf-Watz H
Mol Microbiol; 1998 Jun; 28(6):1067-79. PubMed ID: 9680199
[TBL] [Abstract][Full Text] [Related]
12. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation.
Mukherjee S; Keitany G; Li Y; Wang Y; Ball HL; Goldsmith EJ; Orth K
Science; 2006 May; 312(5777):1211-4. PubMed ID: 16728640
[TBL] [Abstract][Full Text] [Related]
13. Interference of eukaryotic signalling pathways by the bacteria Yersinia outer protein YopJ.
Spiik AK; Meijer LK; Ridderstad A; Pettersson S
Immunol Lett; 1999 Jun; 68(2-3):199-203. PubMed ID: 10424421
[TBL] [Abstract][Full Text] [Related]
14. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
15. The bacterial protein YopJ abrogates multiple signal transduction pathways that converge on the transcription factor CREB.
Meijer LK; Schesser K; Wolf-Watz H; Sassone-Corsi P; Pettersson S
Cell Microbiol; 2000 Jun; 2(3):231-8. PubMed ID: 11207579
[TBL] [Abstract][Full Text] [Related]
16. Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells.
Zhou L; Tan A; Hershenson MB
Respir Physiol Neurobiol; 2004 Apr; 140(1):89-97. PubMed ID: 15109931
[TBL] [Abstract][Full Text] [Related]
17. The activities of the Yersinia protein kinase A (YpkA) and outer protein J (YopJ) virulence factors converge on an eIF2alpha kinase.
Wiley DJ; Shrestha N; Yang J; Atis N; Dayton K; Schesser K
J Biol Chem; 2009 Sep; 284(37):24744-53. PubMed ID: 19553678
[TBL] [Abstract][Full Text] [Related]
18. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
[TBL] [Abstract][Full Text] [Related]
19. Yersinia inhibits host signaling by acetylating MAPK kinases.
Bliska JB
ACS Chem Biol; 2006 Jul; 1(6):349-51. PubMed ID: 17163770
[TBL] [Abstract][Full Text] [Related]
20. Yersinia effector YopJ inhibits yeast MAPK signaling pathways by an evolutionarily conserved mechanism.
Yoon S; Liu Z; Eyobo Y; Orth K
J Biol Chem; 2003 Jan; 278(4):2131-5. PubMed ID: 12433923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
